Vivacta gears up for pilot manufacture of piezofilm assays
10 July 2008
In vitro diagnostics company Vivacta is gearing up for pilot
manufacture of its highly sensitive, disposable piezofilm sensors for
point of care (PoC) diagnostics. It is acquiring an extra 6,000 sq ft of
space within its facility at Kent Science Park, Sittingbourne, UK, and
appointing an experienced engineering manager.
Doubling the size of its operation will allow Vivacta to establish a
fully equipped cartridge pilot facility. This will act as a process
development resource for both its own Development Group and its
The new facility's main role will be to develop and optimise the
process of cartridge manufacture as well as producing batches of up to
10,000 cartridges for internal evaluation and external clinical trials.
Vivacta is already evaluating the first PoC application of its patented
piezofilm technology, for the measurement of thyroid stimulating hormone
To run the new facility, Vivacta has appointed Stafford Moss, as
Engineering Manager. Stafford brings a wealth of experience to the new
operation, having held a similar position at Genosis, a point-of-care
fertility testing business.
Commenting on this latest stage of Vivacta's development, Neil
Butler, CEO, said, "When we raised $12 million from a successful Series
B financing round in 2007, we said it would be used to drive forward the
commercialisation and launch of our first point of care (PoC)
"Acquiring the necessary space for the creation for our Cartridge
Pilot Facility, together with the appointment of Stafford Moss, takes us
another major step closer to the launch of our first commercial assay
and harnessing the speed and sensitivity of our piezofilm technology."
In addition to Mr Moss, Vivacta will be recruiting 10 extra staff
over the next nine months as the new facility ramps up its manufacturing
and quality control functions.